APA
Llorenç V., Cordero-Coma M., Blanco-Esteban A., Heras-Mulero H., Losada-Castillo M., Jovani-Casano V., Valls-Pascual E., Jodar-Marquez M., García-Aparicio Á., Fonollosa A., González-Guijarro J. J., Rodriguez-Melian L., Fernández-Prada M., Jerez-Fidalgo M., Hernandez-Garfella M., Esquinas C., Sainz-de-la-Maza M. & Adán A. (20201211). Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group. : Ophthalmology.
Chicago
Llorenç Victor, Cordero-Coma Miguel, Blanco-Esteban Ana, Heras-Mulero Henar, Losada-Castillo María-José, Jovani-Casano Vega, Valls-Pascual Elia, Jodar-Marquez Margarita, García-Aparicio Ángel, Fonollosa Alejandro, González-Guijarro Juan Jacobo, Rodriguez-Melian Luís, Fernández-Prada Manuel, Jerez-Fidalgo María, Hernandez-Garfella Marisa, Esquinas Cristina, Sainz-de-la-Maza Maite and Adán Alfredo. 20201211. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group. : Ophthalmology.
Harvard
Llorenç V., Cordero-Coma M., Blanco-Esteban A., Heras-Mulero H., Losada-Castillo M., Jovani-Casano V., Valls-Pascual E., Jodar-Marquez M., García-Aparicio Á., Fonollosa A., González-Guijarro J. J., Rodriguez-Melian L., Fernández-Prada M., Jerez-Fidalgo M., Hernandez-Garfella M., Esquinas C., Sainz-de-la-Maza M. and Adán A. (20201211). Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group. : Ophthalmology.
MLA
Llorenç Victor, Cordero-Coma Miguel, Blanco-Esteban Ana, Heras-Mulero Henar, Losada-Castillo María-José, Jovani-Casano Vega, Valls-Pascual Elia, Jodar-Marquez Margarita, García-Aparicio Ángel, Fonollosa Alejandro, González-Guijarro Juan Jacobo, Rodriguez-Melian Luís, Fernández-Prada Manuel, Jerez-Fidalgo María, Hernandez-Garfella Marisa, Esquinas Cristina, Sainz-de-la-Maza Maite and Adán Alfredo. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group. : Ophthalmology. 20201211.